Evidence map›Paper›PMID 36127120›Full record

ArticleBMJ open2022

Cohort profile: life with neurofibromatosis 1 - the Danish NF1 cohort.

Karoline Doser, Hanne Hove, John R Østergaard, Pernille E Bidstrup, Susanne O Dalton, Mette Møller Handrup, Cecilie Ejerskov, Anja Krøyer, Mia Aagaard Doherty, Jens Richardt Møllegaard Jepsen and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Karoline DoserChildhood Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark.
Hanne HoveCenter for Rare Diseases, Department of Pediatrics and Adolescents, Rigshospitalet, Copenhagen, Denmark.
John R ØstergaardCentre for Rare Diseases, Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital Skejby, Aarhus, Denmark.
Pernille E BidstrupPsychological Aspects of Cancer, Danish Cancer Society Research Center, Copenhagen, Denmark.
Susanne O DaltonSurvivorship and Inequality in Cancer, Danish Cancer Society Research Center, Copenhagen, Denmark.
Mette Møller HandrupCentre for Rare Diseases, Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital Skejby, Aarhus, Denmark.
Cecilie EjerskovCentre for Rare Diseases, Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital Skejby, Aarhus, Denmark.
Anja KrøyerChildhood Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark.
Mia Aagaard DohertyChildhood Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark.
Jens Richardt Møllegaard JepsenCenter for Neuropsychiatric Schizophrenia Research and Center for Clinical Intervention, Mental Health Services, Copenhagen University Hospital Glostrup, Glostrup, Denmark.
John J MulvihillDepartment of Pediatrics, University of Oklahoma, Oklahoma City, Oklahoma, USA.
Jeanette F WintherChildhood Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark.
Line KenborgChildhood Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark kenborg@cancer.dk.ORCID 0000-0002-3584-6570
Danish Cancer Society · DKAarhus University Hospital · DKAarhus University · DKMental Health Services · DKRigshospitalet · DKUniversity of Copenhagen · DKUniversity of Oklahoma · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe Danish neurofibromatosis 1 (NF1) cohort was initiated to study health-related, socioeconomic and psychological consequences of living with the monogenetic disorder NF1 using a nationwide and population-based approach.

participantsThe cohort includes all 2467 individuals in Denmark who were hospitalised with or due to NF1 from 1977 to 2013 or registered in the RAREDIS Database (1995-2013), a national clinical database for rare diseases, or both. A comparison cohort matched to individuals with NF1 on sex and date of birth was identified in the Civil Registration System (n=20 132). FINDINGS TO DATE: All cohort members were linked to the unique Danish registries to obtain information on hospital contacts, birth outcomes, education and partnership. A questionnaire was completed by 244 of the 629 adult cohort members with NF1 registered in the RAREDIS Database to evaluate the psychosocial and emotional burden. Further, neuropsychological tests were performed on 103 adult cohort members with NF1 and 38 adult population comparisons. To date, six studies have been published. Individuals with NF1 had an increased risk for (1) hospitalisation for disorders affecting all organ systems of the body throughout all decades of life, (2) psychiatric disorders, (3) attaining a short or medium long education and (4) not forming a life partner. Women with NF1 had an increased risk for spontaneous abortions and stillbirths. Finally, adults with NF1 had an impaired quality of life and a high need for professional support for physical, psychological and work-related problems, which was partly associated with disease severity and visibility. FUTURE PLANS: The cohort will regularly be updated with newly diagnosed patients in the RAREDIS Database as well as with outcome information in the Danish registries. New studies are in progress to assess other medical and socioeconomic dimensions of living with NF1.

Indexed as

Neurofibromatosis 1AdultCohort StudiesDenmarkFemaleHumansPregnancyQuality of LifeRegistriesEPIDEMIOLOGYGENETICSPUBLIC HEALTH

Identifiers

PMID36127120
PMCPMC9490603
OpenAlexW4296519620

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.